Stay updated with breaking news from Nancy Valente. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Xencor, Inc. (NASDAQ:XNCR) Q4 2023 Earnings Call Transcript February 28, 2024 Xencor, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, and thank you for standing by. Welcome to Xencor’s Fourth Quarter and Year End 2023 Conference Call. […]
Operator: Good afternoon and thank you for standing by. Welcome to Xencor’s Third Quarter 2023 Conference Call. Please be advised that this call is going to be recorded at the company’s request.
Xencor, Inc. (NASDAQ:XNCR) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Good afternoon, and thank you for standing by. Welcome to Xencor’s Second Quarter 2023 Conference Call. After the speakers’ presentation there will be a question-and-answer session. [Operator Instructions] Please be advised that this call is going to be recorded at the company’s request. […]
Operator: Good afternoon, and thank you for standing by. Welcome to Xencor's Second Quarter 2023 Conference Call. After the speakers' presentation there will be a question-and-answer session.
ACTengine® IMA203 TCR-T monotherapy against PRAME showed 67% confirmed ORR in an interim clinical update on heavily pre-treated 11 patients in Phase 1b dose expansion Cohort A with median duration of response